Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Daniel Fekade"'
Autor:
Nigus Fikrie Telele, Amare Worku Kalu, Solomon Gebre-Selassie, Daniel Fekade, Gaetano Marrone, Sebastian Grossmann, Ujjwal Neogi, Belete Tegbaru, Anders Sönnerborg
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background Antiretroviral therapy (ART) was rolled-out in Ethiopia in 2005, but there are no reports on outcome of ART and human immunodeficiency virus drug resistance (HIVDR) at national level. We described acquired drug resistance mutation
Externí odkaz:
https://doaj.org/article/b0587b4c4d184371a73a8239506ae58e
Autor:
Nigus Fikrie Telele, Amare Worku Kalu, Solomon Gebre-Selassie, Daniel Fekade, Samir Abdurahman, Gaetano Marrone, Ujjwal Neogi, Belete Tegbaru, Anders Sönnerborg
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-10 (2018)
Abstract Baseline plasma samples of 490 randomly selected antiretroviral therapy (ART) naïve patients from seven hospitals participating in the first nationwide Ethiopian HIV-1 cohort were analysed for surveillance drug resistance mutations (sDRM) b
Externí odkaz:
https://doaj.org/article/fc42cf948ef74e5b9c1993105737a2b2
Autor:
Nigus Fikrie Telele, Amare Worku Kalu, Gaetano Marrone, Solomon Gebre-Selassie, Daniel Fekade, Belete Tegbaru, Anders Sönnerborg
Publikováno v:
PLoS ONE, Vol 13, Iss 7, p e0200505 (2018)
BACKGROUND:Antiretroviral therapy (ART) has been rapidly scaled up in Ethiopia since 2005, but factors influencing the outcome are poorly studied. We therefore analysed baseline predictors of first-line ART outcome after 6 and 12 months. MATERIAL AND
Externí odkaz:
https://doaj.org/article/eea1bb66d09e4ddb8e85c3b6c51e45a6
Autor:
Amare Worku Kalu, Nigus Fikrie Telele, Solomon Gebreselasie, Daniel Fekade, Samir Abdurahman, Gaetano Marrone, Anders Sönnerborg
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0182384 (2017)
Genotypic tropism testing (GTT) has been developed largely on HIV-1 subtype B. Although a few reports have analysed the utility of GTT in other subtypes, more studies using HIV-1 subtype C (HIV-1C) are needed, considering the huge contribution of HIV
Externí odkaz:
https://doaj.org/article/f28978fb62e24db993c3b032de7c4ab1
Autor:
Christopher C Smitson, Admasu Tenna, Mulugeta Tsegaye, Abere S Alemu, Daniel Fekade, Abraham Aseffa, Henry M Blumberg, Russell R Kempker
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e85698 (2014)
There are limited data on clinical outcomes of ART-experienced patients with cryptococcal antigenemia. We assessed clinical outcomes of a predominantly asymptomatic, ART-experienced cohort of HIV+ patients previously found to have a high (8.4%) preva
Externí odkaz:
https://doaj.org/article/4a3e980c091e4a2299e0dfcdb954f2f0
Autor:
Abere Shiferaw Alemu, Russell R Kempker, Admasu Tenna, Christopher Smitson, Nega Berhe, Daniel Fekade, Henry M Blumberg, Abraham Aseffa
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e58377 (2013)
BACKGROUND: Cryptococcal disease is estimated to be responsible for significant mortality in Sub-Saharan Africa; however, only scarce epidemiology data exists. We sought to evaluate the prevalence of and risk factors for cryptococcal antigenemia in E
Externí odkaz:
https://doaj.org/article/febc89d304274113b18a9b8397e9b2f1
Autor:
Belete Tegbaru, Gaetano Marrone, Sebastian Grossmann, Solomon Gebre-Selassie, Anders Sönnerborg, Daniel Fekade, Amare Worku Kalu, Ujjwal Neogi, Nigus Fikrie Telele
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-10 (2019)
BMC Infectious Diseases
BMC Infectious Diseases
Background Antiretroviral therapy (ART) was rolled-out in Ethiopia in 2005, but there are no reports on outcome of ART and human immunodeficiency virus drug resistance (HIVDR) at national level. We described acquired drug resistance mutations in pol
Autor:
Belete Tegbaru, Ujjwal Neogi, Solomon Gebre-Selassie, Daniel Fekade, Samir Abdurahman, Nigus Fikrie Telele, Amare Worku Kalu, Gaetano Marrone, Anders Sönnerborg
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-10 (2018)
Scientific Reports
Scientific Reports
Baseline plasma samples of 490 randomly selected antiretroviral therapy (ART) naïve patients from seven hospitals participating in the first nationwide Ethiopian HIV-1 cohort were analysed for surveillance drug resistance mutations (sDRM) by populat
Autor:
Nigus Fikrie Telele, Solomon Gebre-Selassie, Gaetano Marrone, Amare Worku Kalu, Shambhu G Aralaguppe, Daniel Fekade, Anders Sönnerborg
Publikováno v:
Current HIV research. 16(2)
Objectives:Genotypic Tropism Testing (GTT) tools are generally developed based on HIV-1 subtype B (HIV-1B) and used for HIV-1C as well but with a large discordance of prediction between different methods. We used an established phenotypic assay for c
Autor:
Daniel Fekade, Yibeltal Assefa, Solomon Zewdu, Nicole Simmons, Alula M. Teklu, Achamyeleh Alebachew, William Weiss, Yifru Berhan, Abraham Hailemelak, Yohannes Sitotaw, Girmay Medhin, Melake Damena, Assefa Getachew, Elham Hassen, Eyuel Tsegaye, Tesfalem Hagos, Andrea Ruff
Publikováno v:
Ethiopian Journal of Health Sciences; Vol 27, No 1 (2017): Special Issue; 3-16
Scopus-Elsevier
Ethiopian Journal of Health Sciences
Scopus-Elsevier
Ethiopian Journal of Health Sciences
Background: The purpose of this paper is to describe the establishment of the Advanced Clinical Monitoring of ART Project in Ethiopia for monitoring and evaluation of the longitudinal effectiveness of the ART program and to show the opportunities it